Financial Statements

Bayer Group Consolidated Statements of Financial Position

  [Table 4.3]
  Note Dec. 31, 2013 Dec. 31, 2014
    € million € million
Noncurrent assets      
Goodwill [17] 9,862 16,168
Other intangible assets [17] 8,914 15,653
Property, plant and equipment [18] 10,015 11,428
Investments accounted for using the equity method [19] 203 223
Other financial assets [20] 1,203 1,107
Other receivables [23] 496 447
Deferred taxes [14] 1,596 2,981
    32,289 48,007
Current assets      
Inventories [21] 7,129 8,478
Trade accounts receivable [22] 7,569 9,097
Other financial assets [20] 779 723
Other receivables [23] 1,476 1,488
Claims for income tax refunds   413 588
Cash and cash equivalents   1,662 1,853
    19,028 22,227
       
Total assets   51,317 70,234
       
Equity [24]    
Capital stock of Bayer AG   2,117 2,117
Capital reserves of Bayer AG   6,167 6,167
Other reserves   12,434 11,822
Equity attributable to Bayer AG stockholders   20,718 20,106
Equity attributable to non-controlling interest   86 112
    20,804 20,218
       
Noncurrent liabilities      
Provisions for pensions and other post-employment benefits [25] 7,368 12,236
Other provisions [26] 1,977 2,016
Financial liabilities [27] 5,590 18,484
Other liabilities [29] 362 1,088
Deferred taxes [14] 1,193 689
    16,490 34,513
Current liabilities      
Other provisions [26] 4,727 4,912
Financial liabilities [27] 3,441 3,376
Trade accounts payable [28] 4,473 5,363
Income tax liabilities [26.1] 101 63
Other liabilities [29] 1,281 1,789
    14,023 15,503
       
Total equity and liabilities   51,317 70,234
Last updated: February 26, 2015  Copyright © Bayer AG
http://www.annualreport2014.bayer.com